Abstract
Diagnostic imaging plays a key role in all steps of radiofrequency (RF) tumor ablation:
-
1.
Detection of lesions and selection of patients for treatment;
-
2.
Targeting of lesions and guidance of the procedure;
-
3.
Immediate assessment of treatment result;
-
4.
Long-term follow-up.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001;11(Suppl 3):E15–E26.
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999;210: 655–661.
Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761–768.
Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914–992.
Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow-up in patients. Radiology 1997;202:195–203.
Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205:367–373.
Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159–166.
Livraghi T, Goldberg SN, Solbiati L, Meloni F, Ierace T, Gazelle GS. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001;220:145–149.
De Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR 2000; 175:1619.
Solbiati L, Ierace T, Tonolini M, et al. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001;13:149–158.
Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR 2000;174:691–698.
Vails C, Andia E, Sanchez A, et al. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 2001;218:55–60.
Harvey CJ, Albrecht T. Ultrasound of focal liver lesions. Eur Radiol 2001;11:1578–1593.
Lencioni R, Cioni D, Bartolozzi C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 2002;12: 151–165.
Harvey CJ, Blomley MJK, Eckersley RJ, et al. Hepatic malignancies: improved detection with pulse-inversion US in the late phase of enhancement with SHU 508A—early experience. Radiology 2000;216:903–908.
Albrecht T, Hoffmann CW, Schmitz SA, et al. Phase-inversion sonography during the liver specific late phase of contrast enhancement: improved detection of liver metastases. AJR 2001;176:1191–1198.
Quaia E, Bertolotto M, Forgacs B, et al. Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol 2003;13:475–483.
Albrecht T, Blomley MJK, Burns PN, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003;227:361–370.
Numata K, Isozaki T, Ozawa Y, et al. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR 2003;180:143–149.
Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy. A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR 2000;174: 323–331.
Leyendecker JR, Dodd GD, Halff GA, et al. Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR 2002;178:1147–1151.
Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radio-logic-pathologic correlation. Cancer 2000;88: 2452–2463.
Chopra S, Dodd GD III, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR 2001; 177:381–387.
De Baere T, Elias D, Dromain C, et al. Radio-frequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR 2000;175(6):1619–1625.
Rhim H, Goldberg SN, Dodd GD III, et al. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics 2001;21:S17–S31.
Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluation therapeutic response-preliminary study. Radiology 2000;217:558–563.
Cioni D, Lencioni R, Rossi S, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. AJR 2001;177:783–788.
Solbiati L, Goldberg SN, Ierace T, Delia Noce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent—early experience. Radiology 1999;211: 643–649.
Ding H, Kudo M, Onda H, et al. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US. Comparison with dynamic CT. Radiology 2001;221(3):712–730.
Numata K, Tanaka K, Kiba T, et al. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma. AJR 2001;176: 1199–1205.
Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofre quency ablation. Comparision of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography and helical CT. AJR 2001;177:375–380.
Choi H, Loyer EM, DuBrow RA, et al. Radiofrequency ablation of liver tumors: assessment of therapeutic response and complications. Radio-graphics 2001;21:S41–S54.
Catalano O, Lobianco R, Esposito M, et al. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns. Abdom Imaging 2001;26:375–383.
Dromain C, De Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002;223:255–262.
Sironi S, Livraghi T, Meloni F, et al. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR 1999; 173:1225–1229.
Anderson GS, Brinkmann F, Soulen MC, et al. FDG position emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 2003;28:192–197.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Tonolini, M., Solbiati, L. (2005). Ultrasound Imaging in Tumor Ablation. In: vanSonnenberg, E., McMullen, W.N., Solbiati, L., Livraghi, T., Müeller, P.R., Silverman, S.G. (eds) Tumor Ablation. Springer, New York, NY. https://doi.org/10.1007/0-387-28674-8_11
Download citation
DOI: https://doi.org/10.1007/0-387-28674-8_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95539-1
Online ISBN: 978-0-387-28674-7
eBook Packages: MedicineMedicine (R0)